Off-the-shelf cell therapy pioneer Allogene recruits a Kite vet to run R&D

Bioregnum Opinion Column by John Carroll

After riding out much of a rough year at Instil Bio — capped by a decision to pause and then scrap the lead tumor-infiltrating lymphocyte program and slash more than half the staff — Zachary Roberts will be...

Click to view original post